CONSTELLIUM SE ● The stock, which is currently worth 2019 to 0.71 times its sales, is clearly overvalued in comparison with peers.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● Within the weekly time frame the stock shows a bullish technical configuration above the support level at 11.07 USD
Weaknesses
● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The company sustains low margins.
● The group shows a rather high level of debt in proportion to its EBITDA.
● The group usually releases earnings worse than estimated.
● The company benefits from high valuations in earnings multiples.
● Revenue estimates are regularly revised downwards for the current and coming years.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
